This may be linked to Notch signaling as Sox2 is activated by Notch1 ICD in TNBC [23], and Notch signaling mediates paclitaxel and tamoxifen resistance in colon and breast cancer cells [101,102]. Here, SOX2 is linked to breast cancer.